×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SKYE – skye bioscience, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SKYE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/11
09:35 pm
skye
Skye Bioscience Inc (SKYE) Q4 2025 Earnings Call Highlights: Pioneering Advances in Obesity ... [Yahoo! Finance]
Low
Report
Skye Bioscience Inc (SKYE) Q4 2025 Earnings Call Highlights: Pioneering Advances in Obesity ... [Yahoo! Finance]
3/10
09:07 pm
skye
Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/10
04:01 pm
skye
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Medium
Report
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
3/5
07:41 am
skye
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026 [Yahoo! Finance]
Low
Report
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026 [Yahoo! Finance]
3/5
07:00 am
skye
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026
Low
Report
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026
2/2
07:13 am
skye
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide [Yahoo! Finance]
High
Report
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide [Yahoo! Finance]
2/2
07:00 am
skye
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide
High
Report
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide
1/29
07:00 am
skye
Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference
Low
Report
Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
05:20 pm
skye
Form 8-K Skye Bioscience, Inc. For: Mar 17
Low
Report
Form 8-K Skye Bioscience, Inc. For: Mar 17
3/11
06:01 am
skye
Form S-8 Skye Bioscience, Inc.
Medium
Report
Form S-8 Skye Bioscience, Inc.
3/10
04:05 pm
skye
Form 8-K Skye Bioscience, Inc. For: Mar 10
Medium
Report
Form 8-K Skye Bioscience, Inc. For: Mar 10
3/10
04:03 pm
skye
Form 10-K Skye Bioscience, Inc. For: Dec 31
Medium
Report
Form 10-K Skye Bioscience, Inc. For: Dec 31
2/20
04:05 pm
skye
Form 8-K Skye Bioscience, Inc. For: Feb 13
Low
Report
Form 8-K Skye Bioscience, Inc. For: Feb 13
2/9
09:06 pm
skye
Form 4 Skye Bioscience, Inc. For: Feb 06 Filed by: Schwab Andrew J.
Medium
Report
Form 4 Skye Bioscience, Inc. For: Feb 06 Filed by: Schwab Andrew J.
2/9
08:55 pm
skye
Form 4 Skye Bioscience, Inc. For: Feb 06 Filed by: Smith Karen L.
Medium
Report
Form 4 Skye Bioscience, Inc. For: Feb 06 Filed by: Smith Karen L.
2/9
08:55 pm
skye
Form 4 Skye Bioscience, Inc. For: Feb 06 Filed by: ARSENAULT KAITLYN
Medium
Report
Form 4 Skye Bioscience, Inc. For: Feb 06 Filed by: ARSENAULT KAITLYN
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: